Despite the large number of Americans affected by kidney disease, few new drugs have been approved to treat it in the past decade. To address this issue and to ensure high-quality care for every patient with kidney disease, the American Society of Nephrology (ASN) and the U.S. Food and Drug Administration (FDA) formed a public–private partnership called the Kidney Health Initiative (KHI) in September 2012 to enhance patient safety and foster innovation.
ASN Twitter Feed
RT @CJASN: Kidney Case Conference: How I Treat: Intravascular Volume Assessment in the Critically Ill Patient… https://t.co/auLehiNhJ1
Designing Clinical Trials for Innovative RRT Products
Learn about this new Kidney Health Initiative project in… https://t.co/Dg4dRUNTue
The #KidneyHealthInitiative announces a new project to support the goals of #AdvancingKidneyHealth. The project is… https://t.co/j80aKZWTNN
ASN releases preliminary analysis of AY 2020 Nephrology Match. While total fellows are flat, US MDs declined 14% https://t.co/hYPf8eJIVa
RT @ASNKidney360: Submissions to Kidney360 are welcome on an ongoing basis.
To submit, please go to https://t.co/hGJV97pnBj.
We loo… https://t.co/ajwWKLMMie